{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:34:15Z","timestamp":1789842855131,"version":"4.0.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,13]]},"DOI":"10.7759\/cureus.77400","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T06:00:16Z","timestamp":1736834416000},"source":"Crossref","is-referenced-by-count":2,"title":["B-cell Acute Lymphoblastic Leukemia in a Patient With Crohn\u2019s Disease After Anti-TNF-Alpha Treatment"],"prefix":"10.7759","author":[{"given":"Abded Alraouf","family":"Kawtharani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Akiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Rachid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine S","family":"Geagea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Abi Abboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.01.063","article-title":"Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences","volume":"126","author":"Loftus EV Jr","year":"2004","unstructured":"Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004, 126:1504-17. 10.1053\/j.gastro.2004.01.063","journal-title":"Gastroenterology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2015.34","article-title":"Epidemiology and risk factors for IBD","volume":"12","author":"Ananthakrishnan AN","year":"2015","unstructured":"Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015, 12:205-17. 10.1038\/nrgastro.2015.34","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1403718","article-title":"Cancers complicating inflammatory bowel disease","volume":"372","author":"Beaugerie L","year":"2015","unstructured":"Beaugerie L, Itzkowitz SH. Cancers complicating inflammatory bowel disease. N Engl J Med. 2015, 372:1441-52. 10.1056\/NEJMra1403718","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000509544","article-title":"Malignancies in inflammatory bowel disease","volume":"101","author":"Greuter T","year":"2020","unstructured":"Greuter T, Vavricka S, K\u00f6nig AO, Beaugerie L, Scharl M. Malignancies in inflammatory bowel disease. Digestion. 2020, 101:136-45. 10.1159\/000509544","journal-title":"Digestion"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e318093f4b0","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"46","author":"Jose FA","year":"2008","unstructured":"Jose FA, Heyman MB. Extraintestinal manifestations of inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2008, 46:124-33. 10.1097\/MPG.0b013e318093f4b0","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.056283","article-title":"Acute myeloid leukemia developing in patients with autoimmune diseases","volume":"97","author":"Ramadan SM","year":"2012","unstructured":"Ramadan SM, Fouad TM, Summa V, Hasan SK, Lo-Coco F. Acute myeloid leukemia developing in patients with autoimmune diseases. Haematologica. 2012, 97:805-17. 10.3324\/haematol.2011.056283","journal-title":"Haematologica"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.23950\/jcmk\/10924","article-title":"Acute lymphoid leukemia developing in the course of Crohn's disease: are there any guilty agents?","volume":"18","author":"Ekmen N","year":"2021","unstructured":"Ekmen N, Can G, Sasani H. Acute lymphoid leukemia developing in the course of Crohn's disease: are there any guilty agents?. J Clin Med Kazakhstan. 2021, 18:65-7. 10.23950\/jcmk\/10924","journal-title":"J Clin Med Kazakhstan"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21005","article-title":"Acute lymphoid leukemia in a Crohn's disease patient during treatment with adalimumab after a prolonged treatment with azathioprine and steroids","volume":"16","author":"Cesarini M","year":"2010","unstructured":"Cesarini M, Vernia P, Angelucci E. Acute lymphoid leukemia in a Crohn's disease patient during treatment with adalimumab after a prolonged treatment with azathioprine and steroids. Inflamm Bowel Dis. 2010, 16:371-2. 10.1002\/ibd.21005","journal-title":"Inflamm Bowel Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5606\/ArchRheumatol.2015.5669","article-title":"Acute lymphoid leukemia after anti-TNF-alpha treatment: a case report and review of the literature","volume":"30","author":"Gediz \u00d6zdemirkiran F","year":"2015","unstructured":"Gediz \u00d6zdemirkiran F, Payzin BK, \u00c7oban E, Bayram KB, K\u00fc\u00e7\u00fckzeybek B. Acute lymphoid leukemia after anti-TNF-alpha treatment: a case report and review of the literature. Arch Rheumatol. 2015, 30:349-52. 10.5606\/ArchRheumatol.2015.5669","journal-title":"Arch Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(03)01715-5","article-title":"Acute leukemia after infliximab therapy","volume":"98","author":"Alca\u00edn G","year":"2003","unstructured":"Alca\u00edn G, Andrade RJ, Queipo de Llano MP, Moreno MJ, Garc\u00eda-Cort\u00e9s M, Franquelo E. Acute leukemia after infliximab therapy. Am J Gastroenterol. 2003, 98:2577. 10.1016\/S0002-9270(03)01715-5","journal-title":"Am J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1309\/LMU4KMJDRM3AD6FQ","article-title":"Thyroid cancer and T lymphoblastic leukemia in Crohn disease: a case report and literature review","volume":"46","author":"Byun JM","year":"2015","unstructured":"Byun JM, Baek SK, Yoon HJ, et al.. Thyroid cancer and T lymphoblastic leukemia in Crohn disease: a case report and literature review. Lab Med. 2015, 46:140-5. 10.1309\/LMU4KMJDRM3AD6FQ","journal-title":"Lab Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2014.08.003","article-title":"Relative risk of myelodysplastic syndromes in patients with autoimmune disorders in the General Practice Research Database","volume":"38","author":"Wilson AB","year":"2014","unstructured":"Wilson AB, Neogi T, Prout M, Jick S. Relative risk of myelodysplastic syndromes in patients with autoimmune disorders in the General Practice Research Database. Cancer Epidemiol. 2014, 38:544-9. 10.1016\/j.canep.2014.08.003","journal-title":"Cancer Epidemiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.6435","article-title":"Association of therapy for autoimmune disease With myelodysplastic syndromes and acute myeloid leukemia","volume":"3","author":"Ertz-Archambault N","year":"2017","unstructured":"Ertz-Archambault N, Kosiorek H, Taylor GE, et al.. Association of therapy for autoimmune disease With myelodysplastic syndromes and acute myeloid leukemia. JAMA Oncol. 2017, 3:936-43. 10.1001\/jamaoncol.2016.6435","journal-title":"JAMA Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjaa186","article-title":"TNF inhibitors and risk of malignancy in patients with inflammatory bowel diseases: a systematic review","volume":"15","author":"Muller M","year":"2021","unstructured":"Muller M, D'Amico F, Bonovas S, Danese S, Peyrin-Biroulet L. TNF inhibitors and risk of malignancy in patients with inflammatory bowel diseases: a systematic review. J Crohns Colitis. 2021, 15:840-59. 10.1093\/ecco-jcc\/jjaa186","journal-title":"J Crohns Colitis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-221994","article-title":"Twenty years of biological therapy in an patient with IBD","volume":"2018","author":"Mak WY","year":"2018","unstructured":"Mak WY, Segal JP, Hart A. Twenty years of biological therapy in an patient with IBD. BMJ Case Rep. 2018, 2018:10.1136\/bcr-2017-221994","journal-title":"BMJ Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1159\/000491573","article-title":"Acute myeloid leukemia with myelodysplasia-related changes in a patient with Crohn's disease treated with immunosuppressive therapy","volume":"11","author":"Li B","year":"2018","unstructured":"Li B, Zhu Z, Long S, Li F, Zhu X, Liao W. Acute myeloid leukemia with myelodysplasia-related changes in a patient with Crohn's disease treated with immunosuppressive therapy. Case Rep Oncol. 2018, 11:573-6. 10.1159\/000491573","journal-title":"Case Rep Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.16071","article-title":"Association between use of thiopurines or tumor necrosis factor antagonists alone or in combination and risk of lymphoma in patients with inflammatory bowel disease","volume":"318","author":"Lemaitre M","year":"2017","unstructured":"Lemaitre M, Kirchgesner J, Rudnichi A, Carrat F, Zureik M, Carbonnel F, Dray-Spira R. Association between use of thiopurines or tumor necrosis factor antagonists alone or in combination and risk of lymphoma in patients with inflammatory bowel disease. JAMA. 2017, 318:1679-86. 10.1001\/jama.2017.16071","journal-title":"JAMA"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15538","article-title":"Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post-marketing data","volume":"51","author":"Card T","year":"2020","unstructured":"Card T, Ungaro R, Bhayat F, Blake A, Hantsbarger G, Travis S. Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post-marketing data. Aliment Pharmacol Ther. 2020, 51:149-57. 10.1111\/apt.15538","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/319445-b-cell-acute-lymphoblastic-leukemia-in-a-patient-with-crohns-disease-after-anti-tnf-alpha-treatment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T06:00:18Z","timestamp":1736834418000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/319445-b-cell-acute-lymphoblastic-leukemia-in-a-patient-with-crohns-disease-after-anti-tnf-alpha-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,13]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.77400","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,13]]}}}